Akram Dastagir, M.D.
Specializing in:
Multiple Sclerosis • Immunological Disorders of the Nervous System • Headache Medicine
Akram Dastagir, MD is board-certified in headache medicine and fellowship-trained in multiple sclerosis. Although much of his practice focuses on these conditions, he also likes to work with other neurology issues such as seizures, neuropathy, and Parkinson’s disease. He attended Deccan College of Medical Sciences and is fluent in Urdu and Hindi.
Dr. Dastagir’s belief that MCN is one of the best neurology groups in the country is what directed him to us. Our business model encourages his practice of providing individualized and compassionate care to all his patients and allows him to build long-term relationships with them.
It gives him great joy to be able to help his patients and see improvement. He says, “I have heard patients say that the treatments I provide them has changed their lives. They can spend more time with family and enjoy their life.”
Dr. Dastagir believes that sound sleep habits and regularly staying active are imperative to good overall health.
Having been a player on his college basketball team, Dr. Dastagir remains a devoted hoops fan. Kept happily busy by his three children, he also enjoys traveling, frequenting the outdoors, spending time with family and friends, and trying different types of foods.
Education
- St. Mary’s Junior college, Hyderabad, India
- Medical School – Deccan College of Medical Sciences, Hyderabad, India
- Internship – Deccan College of Medical Sciences, Hyderabad, India
- Residency – Wayne State University, School of Medicine, Department of Neurology, Detroit, MI
- Multiple Sclerosis and Neuroimmunology Fellowship – Harvard Medical School
Certification
- Board Certified – Neurology
- Certificate of Added Qualification in Headache Medicine – National Headache Foundation
Principal Investigator for OMG157/Ofatumumab Clinical Trial with Novartis: A randomized, double-blind, double-dummy, parallel-group phase III study comparing the efficacy and safety of Ofatumumab versus Teriflunomide in patients with Relapsing Multiple Sclerosis. Total budget of around $500,000.00.
- Director of the Multiple Sclerosis Program of Aurora Health Care, Milwaukee, WI, 2016-2020.
- Publication: Article published in ENeurologicalSci Titled: Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis
- Case Report published in Neurol Neuroimmunol Neuroinflamm titled: Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate
- Poster presentation in 2013 American Academy of Neurology on relationship between Vitamin D and Multiple Sclerosis with Dr. Omar Khan at Wayne State University, Detroit, MI
- Poster presentation in 2015 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) on Brain and spinal cord MRI findings in primary progressive vs. relapsing-remitting multiple sclerosis with Dr. Rohit Bakshi at Harvard, Boston, MA
- Poster presentation in 2016 American Academy of Neurology on Brain and spinal cord MRI findings in primary progressive vs. relapsing-remitting multiple sclerosis with Dr. Rohit Bakshi at Harvard, Boston, MA
- Assistant Professor of University of Wisconsin School of Medicine and Public Health.
- Director for the Internal Medicine Resident training in neurology, St. Luke’s Hospital, Milwaukee, WI.
- Preceptor for Nurse Practitioner students for the Marquette University College of Nursing.
Office:
4225 Golden Valley Road
Golden Valley, MN 55422
763-588-0661
Secondary Office:
3400 West 66th Street, Suite 150
Edina, MN 55435
952-920-7200
9645 Grove Circle No., Suite 100
Maple Grove, MN 55369
763-302-4114
Hospital Affiliation:
201 East Nicollet Boulevard
Burnsville, MN 55337
952-892-2000
Schedule Appointment
MyChart by Epic 
952-435-8516 
Request Appointment